Amanote Research

Amanote Research

    RegisterSign In

The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug Targets

Cold Spring Harbor perspectives in medicine - United States
doi 10.1101/cshperspect.a021154
Full Text
Open PDF
Abstract

Available in full text

Categories
BiochemistryMedicineGeneticsMolecular Biology
Date

January 29, 2015

Authors
K. MdluliT. KanekoA. Upton
Publisher

Cold Spring Harbor Laboratory


Related search

The Implications of Model-Informed Drug Discovery and Development for Tuberculosis

Drug Discovery Today
Drug DiscoveryPharmacology
2017English

Drug Discovery and Development: The Final Frontier

Prescriber
Pharmacology
2020English

Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin

Organic Letters
BiochemistryOrganic ChemistryTheoretical ChemistryPhysical
2014English

Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis

Frontiers in Microbiology
Microbiology
2018English

Drug Firms Join Forces to Boost Discovery Pipeline

Nature
Multidisciplinary
2008English

Increasing the Structural Coverage of Tuberculosis Drug Targets

Tuberculosis
Infectious DiseasesImmunologyMicrobiology
2015English

EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design

Journal of Cancer Research Updates
2016English

Wiley Series in Drug Discovery and Development

English

Nuclear Receptors: Emerging Drug Targets for Parasitic Diseases

Journal of Clinical Investigation
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy